Jump to content

Draft:Shore Capital Partners: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Mjiangscp (talk | contribs)
159 edits
No edit summary
Mjiangscp (talk | contribs)
159 edits
No edit summary
Line 28: Line 28:
'''Shore Capital Partners''' (“Shore” or “SCP”) is a [[Chicago]]-based [[Private Equity]] firm focused on [[management buyout]], [[leveraged buyout]], [[corporate divestiture]], [[industry consolidation]], and [[growth capital]] investments in companies operating in the healthcare products and services sectors.<ref>{{cite web|url=http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=61372203 |title=Shore Capital Partners: Private Company Information |publisher=www.bloomberg.com|date= |accessdate=2017-01-12}}</ref>
'''Shore Capital Partners''' (“Shore” or “SCP”) is a [[Chicago]]-based [[Private Equity]] firm focused on [[management buyout]], [[leveraged buyout]], [[corporate divestiture]], [[industry consolidation]], and [[growth capital]] investments in companies operating in the healthcare products and services sectors.<ref>{{cite web|url=http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=61372203 |title=Shore Capital Partners: Private Company Information |publisher=www.bloomberg.com|date= |accessdate=2017-01-12}}</ref>


Founded in 2009, Shore focuses its investments in companies operating in addiction treatment, dermatology, employee assistance programs, home health, interventional products, medical scribes, optometry/ophthalmology, physical therapy, psychiatrist practice management, suboxone clinics, urgent care, vein clinics, and wound care. It invests in companies with strong growth potential in favorable niche segments where the company can help transform the target from a local to regional player.<ref>{{cite web|url=http://www.themiddlemarket.com/news/financial_sponsors/shore-capital-closes-113-million-health-care-fund-250304-1.htmlc |title=Shore Capital &#124; Private Equity &#124; Lower &#124; Middle Market &#124; Investment Parameters |publisher=www.themiddlemarket.com |date= |accessdate=2017-01-12}}</ref>
Founded in 2009, Shore focuses its investments in companies operating in addiction treatment, dermatology, employee assistance programs, home health, interventional products, medical scribes, optometry/ophthalmology, physical therapy, psychiatrist practice management, suboxone clinics, urgent care, vein clinics, and wound care. It invests in companies with strong growth potential in favorable niche segments where the company can help transform the target from a local to regional player.<ref>{{cite web|url=http://www.themiddlemarket.com/news/financial_sponsors/shore-capital-closes-113-million-health-care-fund-250304-1.html |title=Shore Capital &#124; Private Equity &#124; Lower &#124; Middle Market &#124; Investment Parameters |publisher=www.themiddlemarket.com |date= |accessdate=2017-01-12}}</ref>


Shore manages approximately $150 million of equity capital through various investment vehicles including the recently formed Shore Capital Partners Fund I, L.P. with $112.5 million of capital commitments. <ref>{{cite web|url=http://blogs.wsj.com/privateequity/2015/02/24/the-morning-leverage-shore-capital-makes-second-deal-from-first-fund/|title=Shore Capital raises $112.5 million of committed capital|publisher=www.wsj.com |date= |accessdate=2017-01-12}}</ref> The fund typically partners with companies across [[North America]], with a primary focus on the [[United States]].
Shore manages approximately $150 million of equity capital through various investment vehicles including the recently formed Shore Capital Partners Fund I, L.P. with $112.5 million of capital commitments. <ref>{{cite web|url=http://blogs.wsj.com/privateequity/2015/02/24/the-morning-leverage-shore-capital-makes-second-deal-from-first-fund/|title=Shore Capital raises $112.5 million of committed capital|publisher=www.wsj.com |date= |accessdate=2017-01-12}}</ref> The fund typically partners with companies across [[North America]], with a primary focus on the [[United States]].

Revision as of 21:53, 12 January 2017

  • Comment: The concern is that now all the sources here are simply published and republished business announcements and simply because it was published somewhere is not an automatic inheritance of notability; specifically, we need news that is not about company activities such as funding, financials, company quotes, etc. SwisterTwister talk 21:45, 12 January 2017 (UTC)
  • Comment: Resubmitted but without actually removing the listed business announcements and PR notices, and the sources are not actual major independent non-PR sources, so there's nothing to satisfy our basic policies for articles. If you can focus with only major independent non-local non-PR newsz that will help. See WP:Wikipedia is not a directory. SwisterTwister talk 17:54, 12 January 2017 (UTC)
  • Comment: This is a clear advertisement because its sources are simply their own published and republished business announcements and there's no automatic inherited notability from that; this specifically focuses with information hoped to advertise to business partners and clients thus not what articles here are about. SwisterTwister talk 17:10, 12 January 2017 (UTC)
Shore Capital Partners
Company typePrivate
IndustryPrivate Equity
Founded2009
HeadquartersChicago, Illinois, United States
Key people
Justin Ishbia, Ryan Kelley (Private Equity), Mike Cooper (Private Equity), John Hennegan, Don Pierce
ProductsLeveraged buyout, Growth capital, Management buyout, Recapitalization, Industry consolidation
Total assets$150 million (assets under management)[1]
Number of employees
15+
Websitewww.shorecp.com

Shore Capital Partners (“Shore” or “SCP”) is a Chicago-based Private Equity firm focused on management buyout, leveraged buyout, corporate divestiture, industry consolidation, and growth capital investments in companies operating in the healthcare products and services sectors.[2]

Founded in 2009, Shore focuses its investments in companies operating in addiction treatment, dermatology, employee assistance programs, home health, interventional products, medical scribes, optometry/ophthalmology, physical therapy, psychiatrist practice management, suboxone clinics, urgent care, vein clinics, and wound care. It invests in companies with strong growth potential in favorable niche segments where the company can help transform the target from a local to regional player.[3]

Shore manages approximately $150 million of equity capital through various investment vehicles including the recently formed Shore Capital Partners Fund I, L.P. with $112.5 million of capital commitments. [4] The fund typically partners with companies across North America, with a primary focus on the United States.

References

  1. ^ "$150 million in equity under management". www.mergr.com. Retrieved 2017-01-12.
  2. ^ "Shore Capital Partners: Private Company Information". www.bloomberg.com. Retrieved 2017-01-12.
  3. ^ "Shore Capital | Private Equity | Lower | Middle Market | Investment Parameters". www.themiddlemarket.com. Retrieved 2017-01-12.
  4. ^ "Shore Capital raises $112.5 million of committed capital". www.wsj.com. Retrieved 2017-01-12.

Category:Private equity firms of the United States Category:Shore Capital Partners Category:Companies established in 2009 Category:Companies based in Chicago Category:2009 establishments in Chicago

Stub icon 1 Stub icon 2

This article about a private equity or venture capital firm based in the United States is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Shore_Capital_Partners&oldid=759733627"